News & Opinions | Regenerative Medicine Foundation

Addressing the problem of “bad actors”! Regenerative Medicine Foundation and Alliance for Cell Therapy NOW organize educational briefing for U.S. House and Senate – Washington, D.C.

by Admin | Sep 16, 2019 | News & Opinions

September 19th 12pm – 1:30pm ET (lunch will be served) at 902 Hart Senate Office Building Regenerative cellular therapies represent the next generation of groundbreaking treatments that are showing great promise in cardiology, neurology, oncology, orthopedics,...

Study shows Mesenchymal Stromal Cells importance of tissue origin in predicting function

by admin | Sep 12, 2019 | News & Opinions

DURHAM, N.C. (PRWEB)September 10, 2019 – A new study released today in STEM CELLS demonstrates that mesenchymal stromal cells (MSCs) expanded from adipose tissue (ASC) outperform those expanded from bone marrow (BM-MSCs). Importantly, while several previous...

Bernie Siegel: Observations on my 70th birthday

by Admin | Sep 10, 2019 | News & Opinions

Today (9/11), I am entering my 8th decade! I’m remembering snippets from the lyrics from the old Simon and Garfunkel song “Old Friends”: “Old Friends. Old Friends. Sat on the park bench like bookends… Preserve your memories. They’re all that’s left you…How terribly...

At last! Google policy bars ads for unproven stem cell and gene therapies – acknowledges “good actors”

by Admin | Sep 9, 2019 | News & Opinions

September 6, 2019 – Digital advertising helps fuel an open internet for people all over the world — allowing billions of people to ask questions, find answers, and discover new ideas. We know the digital ads ecosystem can only flourish if it’s a place that...

Study shows stem cells may be better choice than tissue transplantation for treating LSCD

by Admin | Sep 5, 2019 | News & Opinions

Durham, NC – Results of a phase II clinical trial released today in STEM CELLS Translational Medicine (SCTM) indicate that a limbal stem cell (LSC) transplantation is superior to a tissue graft in treating limbal stem cell deficiency syndrome (LSCD). This could result...

FDA sends warning to company for selling unapproved umbilical cord blood and umbilical cord products that may put patients at risk; continues to warn patients of the risk of unapproved stem cell therapy

by Admin | Sep 4, 2019 | News & Opinions

Stemell sold stem cell products without required FDA approval The U.S. Food and Drug Administration has warned Stemell, Inc. (Stemell), of San Juan Capistrano, California, and its president and Chief Executive Officer, Peyman Taeidi, Ph.D., for manufacturing and...